The Mandate Gap — What the Waiver Will Ask For

Eighteen months remain before the January 1, 2028 Section 4865 deadline covering all battery types in new acquisition programs. No public DFARS clause, waiver template, or implementation artifact has appeared; that finding is established and unchanged. What changed since late June is the procedural environment surrounding Section 4865. Two adjacent enforcement regimes published their waiver documentation requirements, and together they define the floor for what battery waivers will demand when the machinery becomes visible.

Gap math

Eighteen months to the new-program deadline. QPL-32565 lists zero qualified manufacturers and zero products. Typical defense battery qualification from first article through production approval runs 18–36 months depending on the application. Any supplier not already in qualification will not clear the January 2028 gate through the front door. The waiver channel is the only bridge, and the waiver channel has no public operating procedure.

The two analogs that did publish procedural requirements in the last four weeks define the minimum documentation burden.

The procedural analogs

Section 805. The Department of War launched its Section 805 waiver site on June 30, 2026, covering FY2024 NDAA restrictions on procurement from 1260H-listed Chinese military companies. The waiver package requires three things: a compelling justification narrative addressing mission criticality and lack of mature market alternatives, a detailed entity phase-out plan with milestones, dedicated resources, and timelines, and product identification down to part numbers and model numbers. The intake form includes "Energy Storage & Batteries (e.g., Lithium-ion)" as a product category. Absent a formal, signed waiver, the company remains subject to DFARS 225.773-2.

The July 20 EO. The executive order titled "Securing America's Defense Supply Chains and Ensuring Domestic Acquisition of Critical Materials" targets 10 U.S.C. 4872 covered materials: specialty metals, magnets, tantalum, tungsten. Effective January 1, 2027, the Secretary of War ceases issuing 4872(c)(1) waivers except where the prime or subcontractor submits a mitigation plan meeting four requirements: identify the noncompliant source, document exhaustive efforts to acquire compliant material, describe steps to remove the noncompliant source from the supply chain, and establish a strict projected timeline for complete implementation.

Three provisions carry enforcement weight beyond the mitigation plan itself. Section 2(c) states that failure to qualify a domestic source does not constitute nonavailability unless the contractor demonstrates "active, adequately funded, and ongoing efforts" to qualify one. Section 2(d) directs contractual remedies for fraud, deliberate misleading, or knowing failure to implement an approved plan. Section 3 requires, within 270 days, regulations mandating a complete indentured bill of materials tracing components back to raw-material origin, with 15-day notification for significant supply-chain risks identified after vetting.

Neither analog governs batteries directly. Both reveal the procedural culture that Section 4865 waivers will inherit.

Why batteries are structurally harder to document

Each regime asks a different kind of question. The difficulty of answering it scales with the number of independent supply-chain determinations required.

Section 805 asks a binary question: is your supplier on the 1260H list, or controlled by an entity on it? The documentation burden is real, but the underlying determination is a lookup. You identify the entity. You check the list.

Section 4872 asks a material-origin question: where was this metal melted, or this magnet sintered? Answering it requires supply-chain tracing, but the object being traced is a single material with a defined production step. The existing PGI 225.7018-4 nonavailability template for covered magnets and specialty metals already demands component name, covered material, current manufacturer, country of origin, material specification, quantity, unit price, and the same fields for every alternative compliant source considered. A government representative must independently verify the information.

Section 4865 asks a quantitative cost-allocation question: do functional cell components comprising more than 95 percent of functional-cell-component costs originate from non-FEOC sources? The statute defines "functional cell component" to include cathode materials, anode materials, separators, anode foils, solvents, additives, electrolyte salts, and internal safety devices. A waiver applicant would need to allocate costs across each of these categories, trace each to FEOC or non-FEOC origin, and demonstrate that the 95% threshold cannot be met. And this is not a one-time filing. It is a recurring, auditable determination.

Apply the July 20 EO's four mitigation-plan requirements to this structure. Identify which CAM supplier, which separator manufacturer, which electrolyte salt producer is FEOC-sourced. Document which non-FEOC alternatives were evaluated, at what cost, at what qualification timeline, and why they were not selected. Describe which components will be re-sourced and in what sequence. Set a strict timeline for when each substitution reaches qualified status. The EO's bill-of-materials tracing requirement, extended to batteries, would demand visibility into the cell manufacturer's component supply chain at a level most cell makers treat as proprietary.

The structural problem is that the 95% cost test requires cost-origin data that lives with the cell manufacturer, not with the defense contractor filing the waiver. When a domestic assembler uses a partner's formulations and supply chain, as prior analysis documented, the FEOC component-cost test becomes nearly unassessable from the contractor's position without the cell maker's active, detailed cooperation. The documentation burden falls on a supply chain that has no established mechanism for producing the required cost-allocation artifacts. The contractor cannot generate what the cell maker will not disclose, and the cell maker has no regulatory obligation to disclose it.

Implications for the gap

The Section 4865 waiver provision allows the Secretary (delegable only to USD(A&S)) to waive compliance for a specific system or battery for one year, on a finding that compliant batteries of satisfactory quality and sufficient quantity cannot be acquired as and when needed at reasonable cost. The statute is silent on mitigation plans, phase-out timelines, or bill-of-materials documentation.

The procedural culture is not silent. The July 20 EO's explicit statement that failure to qualify a domestic source does not constitute nonavailability absent active, funded qualification efforts will apply to batteries by analogy if not by regulation.

QPL-32565 lists zero qualified manufacturers and zero products. Under the procedural standard the EO establishes for adjacent materials, a program office cannot simply point to that empty QPL and assert nonavailability. It would need to demonstrate that it is actively funding qualification of a compliant source and that the waiver is a bridge to a specific, time-bound compliance outcome.

The documentation burden modeled here is editorial inference, not confirmed policy. No Section 4865 DFARS clause or waiver procedure has been published. The direction, however, is visible across both analogs that published in June and July 2026: source identification, alternatives analysis, removal plans, strict timelines. Both impose consequences for misrepresentation. Neither accepts nonavailability as an assertion.

When the battery waiver machinery appears, it will ask for component-level cost-origin documentation that no public supplier has demonstrated the ability to produce. The gap between mandate and qualified supply is well established. The gap between mandate and the documentation infrastructure needed to prove that supply falls short is a second problem, and it compounds the first. A contractor that cannot source a compliant battery and cannot produce the cost-allocation data to prove noncompliance is stuck on both sides of the waiver gate.

Other deadlines

January 2029, standard batteries. No public DFARS implementation artifact. No significant change since the prior update. Gap assessment: static.

January 2031, existing acquisition programs. No significant change. Longest runway, same documentation burden. Static.